Avrio Biopharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Avrio Biopharmaceuticals Ownership

Who owns Avrio Biopharmaceuticals?

Avrio Biopharmaceuticals is owned by Nitto Denko Avecia. It was acquired on October 12, 2016.

Avrio Biopharmaceuticals Business Overview

Where is Avrio Biopharmaceuticals headquartered?

Avrio Biopharmaceuticals is headquartered in Irvine, California.

What sector is Avrio Biopharmaceuticals in?

Avrio Biopharmaceuticals is a life science company.

When was Avrio Biopharmaceuticals founded?

Avrio Biopharmaceuticals was founded in 2008.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 292 acquisitions of life science companies in 2016, including 31 acquisitions by private equity firms, and 261 by strategics.

Avrio Biopharmaceuticals LLC

4 Chrysler,
Irvine, California 92618
United States,
(949) 462-0814

Avrio Biopharmaceuticals LLC is a cGMP contract development and manufacturing organization supporting the pharmaceutical and biopharmaceutical industries from Phase I through post-market life cycle management. With a state-of-the-art facility, experienced staff, and robust quality infrastructure, Avrio delivers client-centric solutions in a timely manner.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.